Sonata Therapeutics trademark - biopharma research services
Summary
USPTO received Intent to Use trademark application TM97420640 for SONATA THERAPEUTICS covering scientific research, pharmaceutical R&D, and medical research services in biotechnology; platform-as-a-service for computational biology and bioinformatics; and pharmaceutical compositions for cellular signal modulation treating cancer, fibrotic diseases, immune/inflammatory diseases, neurological diseases, infectious diseases, and tissue degenerative diseases.
What changed
Sonata Therapeutics filed Intent to Use trademark application TM97420640 with the USPTO on May 20, 2022, for the mark SONATA THERAPEUTICS covering International Class 042 technology services including scientific research, pharmaceutical research, medical research, product development in biotechnology, computational biology, bioinformatics, genomics platforms, and platform-as-a-service software. The application also covers pharmaceutical agents, therapeutic products, and pharmaceutical compositions for cellular signal modulation treating multiple disease categories including cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious diseases, tissue degenerative diseases, and regenerative medicine.
This is a routine trademark application filing with no immediate compliance obligations for third parties. Pharmaceutical and biotechnology companies should review the listed goods and services to identify potential conflicts with their own trademarks or pending applications in Class 042. Companies operating in computational biology, bioinformatics, or genomics research services should assess whether Sonata Therapeutics' trademark scope overlaps with their own IP holdings.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
SONATA THERAPEUTICS
Intent to Use TM97420640 Kind: intenttouse Apr 02, 2026
Abstract
Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; technical scientific research consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; Pharmaceutical agents and products, namely, pharmaceutical agents for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical compositions in the nature of chemical and biological small molecules, namely, pharmaceutical preparations for the treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation, namely, pharmaceutical preparations for the treatment of cancer
Filing Date
2022-05-20
Named provisions
Related changes
Get daily alerts for USPTO Trademarks - Technology Services (Class 042)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Technology Services (Class 042) publishes new changes.